EQRx
Biotechnology ResearchMassachusetts, United States201-500 Employees
Effective 11/09/23, EQRx., Inc. is now a wholly-owned subsidiary of Revolution Medicines (https://www.revmed.com/)
Insights
Acquisition Opportunities EQRx recently merged with Revolution Medicines, pointing towards potential synergies between the two companies and a chance to offer combined biotechnology research solutions to a wider market.
Strategic Collaboration The partnership between EQRx and Revolution Medicines opens the door for strategic collaborations with other players in the biotechnology industry, showcasing a collaborative approach towards innovation and product development.
Financial Strength With a funding of $1.2B and a revenue range of $10M - 50M, EQRx positioned itself as a financially robust player, indicating stability and potential for large-scale deals and partnerships.
Leading Technology Stack EQRx boasts a comprehensive tech stack including Python, JavaScript, TensorFlow, and more, signifying a commitment to cutting-edge technologies that can attract tech-savvy clients seeking innovative solutions.
Market Expansion Potential The acquisition of EQRx by Revolution Medicines hints at market expansion opportunities, allowing EQRx to tap into new geographic areas and customer segments through the established network of Revolution Medicines.
Similar companies to EQRx
Skyhawk Therapeutics
71
$10M$50MKronos Bio
70$10M$50MCorvidia Therapeutics
11Syros Pharmaceuticals
90$10M$50MKymera Therapeutics
204$10M$50MFlagship Pioneering
695$50M$100MRheos Medicines
29Omega Therapeutics
86$10M$50MGoldfinch Bio
11$10MRelay Therapeutics
281$10M$50MTango Therapeutics
176$10M$50MCelsius Therapeutics
11$10M
EQRx Tech Stack
EQRx uses 8 technology products and services including jsDelivr, ADP, Slick, and more. Explore EQRx's tech stack below.
- jsDelivrContent Delivery Network
- ADPHuman Resource Management System
- SlickJavascript Libraries
- jQueryJavascript Libraries
- TensorFlowMachine Learning
- PythonProgramming Languages
- JavaScriptProgramming Languages
- PerlProgramming Languages
Media & News
EQRx's Email Address Formats
EQRx uses at least 2 format(s):
| EQRx Email Formats | Percentage |
| FLast@eqrx.com | 94% |
| Last@eqrx.com | 4% |
| FMiddleLast@eqrx.com | 1% |
| First@eqrx.com | 1% |
| FLast@revmed.com | 77% |
| First@revmed.com | 22% |
| Last@revmed.com | 1% |
Frequently Asked Questions
Where is EQRx's headquarters located?
EQRx's main headquarters is located at Cambridge, MA US. The company has employees across 4 continents, including North AmericaEuropeSouth America. What is EQRx's stock symbol?
EQRx is a publicly traded company; the company's stock symbol is EQRX. What is EQRx's official website and social media links?
EQRx's official website is revmed.com and has social profiles on LinkedIn.How much revenue does EQRx generate?
As of December 2023, EQRx's annual revenue reached $35M. What is EQRx's SIC code NAICS code?
EQRx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does EQRx have currently?
As of December 2023, EQRx has approximately 201 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: M. N.Chief Compliance And Risk Officer: C. C.Chief Financial Officer: J. R.. Explore EQRx's employee directory with LeadIQ.What industry does EQRx belong to?
EQRx operates in the Biotechnology Research industry. What technology does EQRx use?
EQRx's tech stack includes jsDelivrADPSlickjQueryTensorFlowPythonJavaScriptPerl. What is EQRx's email format?
EQRx's email format typically follows the pattern of . Find more EQRx email formats with LeadIQ. How much funding has EQRx raised to date?
As of December 2023, EQRx has raised $1.2B in funding. The last funding round occurred on Dec 17, 2021 for $1.2B.When was EQRx founded?
EQRx was founded in 2019.
Company Overview
- Headquarters
- Cambridge, MA US
- Website
- revmed.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- EQRX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2019
- Employees
- 201-500
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Company Leadership
M. N.Chief Executive Officer- C. C.Chief Compliance And Risk Officer
- J. R.Chief Financial Officer
K. R.Chief Customer Officer
T. P.Chief Regulatory Officer
Employee Directory
- L. G.Founder And Partner
- P. M.Talent Acquistion Partner
- R. F.Co-Founder And Cxo
- S. H.Co-Founder
- T. P.Chief Regulatory Officer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
